Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts

Immunoglobulin light chain (AL) amyloidosis is a progressive plasma cell dyscrasia which is characterized by the deposition of amyloid fibers derived from immunoglobulin light chain or their fragments systemically in many organs.[1][1] The characteristics of amyloids relate to disease severity and

Bibliographic Details

Main Authors:	Meziane, Iman (Author) , Huhn, Stefanie (Author) , Weinhold, Niels (Author) , Nickel, Jolanta (Author) , Jauch, Anna (Author) , Goldschmidt, Hartmut (Author) , Hegenbart, Ute (Author) , Schönland, Stefan (Author)
Format:	Article (Journal)
Language:	English
Published:	October 2017
In:	Haematologica Year: 2017, Volume: 102, Issue: 10, Pages: e411-e414
ISSN:	1592-8721
DOI:	10.3324/haematol.2017.171108
Online Access:	Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2017.171108 Verlag, Volltext: http://www.haematologica.org/content/102/10/e411
Author Notes:	Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Niels Weinhold, Chiara Campo, Jolanta Nickel, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Stefano Landi, Jonathan S. Mitchell, David Johnson, Anna Jauch, Gareth J. Morgan, Richard Houlston, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Asta Försti, Stefan O. Schönland, Kari Hemminki